Synaptogenix (NASDAQ:SNPX) Trading Down 5.6% – Time to Sell?

Synaptogenix, Inc. (NASDAQ:SNPX) shares traded down 5.6% during mid-day trading on Tuesday . The stock traded as low as $2.82 and last traded at $2.84. 3,691 shares traded hands during trading, a decline of 78% from the average session volume of 17,126 shares. The stock had previously closed at $3.01.

Synaptogenix Price Performance

The stock has a 50-day moving average of $3.21 and a 200 day moving average of $3.19.

Hedge Funds Weigh In On Synaptogenix

An institutional investor recently bought a new position in Synaptogenix stock. Geode Capital Management LLC acquired a new stake in shares of Synaptogenix, Inc. (NASDAQ:SNPX) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 10,844 shares of the company’s stock, valued at approximately $39,000. Geode Capital Management LLC owned approximately 0.80% of Synaptogenix at the end of the most recent reporting period. Hedge funds and other institutional investors own 10.34% of the company’s stock.

About Synaptogenix

Synaptogenix, Inc operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease.